PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 164 filers reported holding PRECIGEN INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $181,157 | -40.1% | 127,575 | -51.5% | 0.03% | -42.6% |
Q2 2023 | $302,503 | -31.2% | 263,046 | -36.6% | 0.05% | -41.3% |
Q1 2023 | $439,600 | -5.6% | 414,717 | +35.4% | 0.09% | -7.1% |
Q4 2022 | $465,625 | +497.0% | 306,332 | +728.7% | 0.10% | +421.1% |
Q3 2022 | $78,000 | -20.4% | 36,965 | -49.3% | 0.02% | -52.5% |
Q2 2022 | $98,000 | -15.5% | 72,898 | +32.1% | 0.04% | -21.6% |
Q1 2022 | $116,000 | +127.5% | 55,195 | +301.4% | 0.05% | +75.9% |
Q4 2021 | $51,000 | -47.4% | 13,752 | -2.3% | 0.03% | -38.3% |
Q1 2021 | $97,000 | – | 14,070 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
EMFO, LLC | 425,000 | $603,500 | 0.57% |
Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
First Washington CORP | 646,575 | $918,137 | 0.37% |
Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |